Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/17/2017 11/20/2017 11/21/2017 11/22/2017 11/24/2017 Date
35.37(c) 35.35(c) 35.54(c) 35.43(c) 35.49(c) Last
14 847 477 11 817 430 12 649 953 10 553 135 6 397 307 Volume
-0.53% -0.06% +0.54% -0.31% +0.17% Change
More quotes
Financials ($)
Sales 2017 52 541 M
EBIT 2017 19 883 M
Net income 2017 10 977 M
Debt 2017 23 944 M
Yield 2017 3,61%
Sales 2018 53 956 M
EBIT 2018 21 054 M
Net income 2018 12 891 M
Debt 2018 23 221 M
Yield 2018 3,82%
P/E ratio 2017 18,95
P/E ratio 2018 16,46
EV / Sales2017 4,48x
EV / Sales2018 4,34x
Capitalization 211 B
More Financials
Company
Pfizer, Inc. engages in the manufacture of vaccines and injectable biologic medicines.It operates through the Pfizer Innovative Health and Pfizer Essential Health segments.The Pfizer Innovative Health segment focuses on developing and commercializing novel, value-creating medicines, and vaccines... 
Sector
Pharmaceuticals
Calendar
12/09Presentation
More about the company
Surperformance© ratings of Pfizer
Trading Rating : Investor Rating :
More Ratings
Latest news on PFIZER
03:11p PFIZER : The USA’s Musculoskeletal Drugs Market To Fall As A Share Of The ..
09:32a PFIZER : ViiV Healthcare`s two-drug regimen, Juluca receives US FDA approval for..
11/23 PFIZER : ViiV Healthcare announces US FDA approval for Juluca
11/23 PFIZER : GSK group of companies - Juluca approved in US as first 2-drug regimen,..
11/23 RESEARCHERS AT WASHINGTON UNIVERSITY : DiviTum® can evaluate the biologic activi..
11/22 PFIZER : demands return of drugs set for use in US lethal injections
11/22 U.S. FDA approves first two-drug HIV regimen in win for GSK
11/22 PFIZER : Juluca® (dolutegravir and rilpivirine) approved in US as first 2-drug r..
11/21 PFIZER : Data on Clinical Research Detailed by Researchers at Pfizer (mTORC1 sti..
11/21 PFIZER : New Biochemistry Findings from Pfizer Described (Microfluidic-Enabled I..
More news
Sector news : Pharmaceuticals - NEC
09:31aDJBAYER : Amikacin Inhale Fails to Meet Objectives in Phase 3 Trial
11/23 German chemicals companies should review British ops - trade body
11/23DJGLAXOSMITHKLINE : Files Additional Trelegy Ellipta Application to FDA
11/22 BAYER : Brazil pushes back decision on Bayer-Monsanto tie-up
11/22 European shares retreat on euro bounce; UK flat after budget
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on PFIZER 
PFIZER INC. - 2016
Expectation of a turn-around
BUY
PFIZER INC. - 2016
Back on a long term support level
BUY
More Strategies
News from SeekingAlpha
11/22 Cabozantinib Franchise Will Continue To Transform Exelixis' Fortunes In 2018
11/22 THE NEXT BILLION DOLLAR BLOCKBUSTER : Why Value Investors Should Look At Omeros ..
11/22 YOUR DAILY PHARMA SCOOP : Teva Valuation, DelMar Lead Candidate, Galapagos Comme..
11/22 Mystery Stocks Revealed In My 88 Stock Portfolio Along With 2018 Income Estim..
11/22 Trading Quality Stocks And Short Term Rates Higher Update
Chart PFIZER
Duration : Period :
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Technical analysis trends PFIZER
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 38,2 $
Spread / Average Target 7,7%
EPS Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
W. Don Cornwell Independent Director
Dennis Arthur Ausiello Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER9.08%211 188
JOHNSON & JOHNSON19.17%368 832
NOVARTIS12.82%222 846
ROCHE HOLDING LTD.6.15%216 979
MERCK AND COMPANY-7.64%148 286
AMGEN16.24%123 376